Correlation Between Sarepta Therapeutics and CureVac NV
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and CureVac NV, you can compare the effects of market volatilities on Sarepta Therapeutics and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and CureVac NV.
Diversification Opportunities for Sarepta Therapeutics and CureVac NV
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sarepta and CureVac is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and CureVac NV go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and CureVac NV
Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the CureVac NV. But the stock apears to be less risky and, when comparing its historical volatility, Sarepta Therapeutics is 1.3 times less risky than CureVac NV. The stock trades about -0.3 of its potential returns per unit of risk. The CureVac NV is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 270.00 in CureVac NV on August 24, 2024 and sell it today you would lose (14.00) from holding CureVac NV or give up 5.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. CureVac NV
Performance |
| Timeline |
| Sarepta Therapeutics |
| CureVac NV |
Sarepta Therapeutics and CureVac NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and CureVac NV
The main advantage of trading using opposite Sarepta Therapeutics and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
| CureVac NV vs. ZyVersa Therapeutics | CureVac NV vs. Sonnet Biotherapeutics Holdings | CureVac NV vs. Zura Bio Limited | CureVac NV vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |